Cargando…

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooks, Tomer, Pateras, Ioannis S., Jenkins, Lisa M., Patel, Keval M., Robles, Ana I., Morris, James, Forshew, Tim, Appella, Ettore, Gorgoulis, Vassilis G., Harris, Curtis C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823939/
https://www.ncbi.nlm.nih.gov/pubmed/29472616
http://dx.doi.org/10.1038/s41467-018-03224-w
_version_ 1783301959758905344
author Cooks, Tomer
Pateras, Ioannis S.
Jenkins, Lisa M.
Patel, Keval M.
Robles, Ana I.
Morris, James
Forshew, Tim
Appella, Ettore
Gorgoulis, Vassilis G.
Harris, Curtis C.
author_facet Cooks, Tomer
Pateras, Ioannis S.
Jenkins, Lisa M.
Patel, Keval M.
Robles, Ana I.
Morris, James
Forshew, Tim
Appella, Ettore
Gorgoulis, Vassilis G.
Harris, Curtis C.
author_sort Cooks, Tomer
collection PubMed
description TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis.
format Online
Article
Text
id pubmed-5823939
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58239392018-02-26 Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246 Cooks, Tomer Pateras, Ioannis S. Jenkins, Lisa M. Patel, Keval M. Robles, Ana I. Morris, James Forshew, Tim Appella, Ettore Gorgoulis, Vassilis G. Harris, Curtis C. Nat Commun Article TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis. Nature Publishing Group UK 2018-02-22 /pmc/articles/PMC5823939/ /pubmed/29472616 http://dx.doi.org/10.1038/s41467-018-03224-w Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cooks, Tomer
Pateras, Ioannis S.
Jenkins, Lisa M.
Patel, Keval M.
Robles, Ana I.
Morris, James
Forshew, Tim
Appella, Ettore
Gorgoulis, Vassilis G.
Harris, Curtis C.
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title_full Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title_fullStr Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title_full_unstemmed Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title_short Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
title_sort mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal mir-1246
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823939/
https://www.ncbi.nlm.nih.gov/pubmed/29472616
http://dx.doi.org/10.1038/s41467-018-03224-w
work_keys_str_mv AT cookstomer mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT paterasioanniss mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT jenkinslisam mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT patelkevalm mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT roblesanai mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT morrisjames mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT forshewtim mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT appellaettore mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT gorgoulisvassilisg mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246
AT harriscurtisc mutantp53cancersreprogrammacrophagestotumorsupportingmacrophagesviaexosomalmir1246